{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-267275","form_type":"8-K","ticker":"DBVT","cik":"0001613780","company_name":"DBV Technologies S.A.","filed_at":"2023-10-31T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.779774+00:00","generated_at":"2026-06-09T04:44:16.073330+00:00","sec_items":["1.02","2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"DBV reports Q3 net loss, $149M cash; FDA clarifies COMFORT studies; terminates Nestlé deal","bullets":["FDA provided written feedback harmonizing COMFORT Toddlers/Children protocol design; COMFORT Toddlers uses same eligibility as EPITOPE (DBPCFC required).","Cash $149.1M (Dec 31 2022: $209.2M); 9M 2023 net loss $61.5M ($0.65/share) vs $57.0M loss in 9M 2022.","Terminated Nestlé collaboration (MAG1C atopy patch test) effective Oct 30, 2023; APTITUDE study ended; no further milestones.","First COMFORT Toddlers subject enrollment expected Q1 2024; COMFORT Children start after VITESSE recruitment."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-267275","json":"https://secwatch.observer/filing/0001193125-23-267275.json","markdown":"https://secwatch.observer/filing/0001193125-23-267275.md","text":"https://secwatch.observer/filing/0001193125-23-267275.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1613780/000119312523267275/0001193125-23-267275-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1613780/000119312523267275/d495430d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T04:44:16.073330+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"720a2f484beec5baf45b6606df7fb494f07ecc6a","claim":"DBV Technologies S.A. reported financial results for third quarter of 2023.","evidence_excerpt":"On October 31, 2023, the Company issued a press release announcing financial results and business highlights for the fiscal quarter ended September 30, 2023.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1613780/000119312523267275/0001193125-23-267275-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"third quarter of 2023"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"1f1b46342948435d92afb178c3d4b6c283d5ea4e","claim":"DBV Technologies S.A. terminated Collaboration Agreement with Société des Produits Nestlé S.A. (formerly NESTEC S.A.) (effective 2023-10-30).","evidence_excerpt":"On October 30, 2023, the Company and NESTEC entered into a Mutual Termination Letter Agreement terminating the Collaboration Agreement.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1613780/000119312523267275/0001193125-23-267275-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"termination"},{"label":"Agreement","value":"collaboration"},{"label":"Counterparty","value":"Société des Produits Nestlé S.A. (formerly NESTEC S.A.)"},{"label":"Effective","value":"2023-10-30"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}